7Baggers
 glycomimetics inc (glyc) valuation: pe, pb & fair value analysis  TradingKey Thu, 18 Jun 2026 09:17:13 GMT
 GlycoMimetics Inc (GLYC) Institutional Confidence  TradingKey Wed, 17 Jun 2026 22:54:24 GMT
 CBIO - Crescent Biopharma Inc Stock Price and Quote  Finviz Tue, 26 May 2026 13:59:30 GMT
 why is glycomimetics, inc. (glyc) stock down today?  Meyka Tue, 19 May 2026 01:58:38 GMT
 tradingkey  TradingKey Wed, 13 May 2026 20:07:56 GMT
 glycomimetics, inc. - common stock (nq: glyc  FinancialContent Wed, 13 May 2026 19:09:01 GMT
 revenue of glycomimetics from 2020 to 2025  Statista Wed, 25 Mar 2026 07:00:00 GMT
 glycomimetics revenue 2020-2025  statista.com Wed, 25 Mar 2026 07:00:00 GMT
 glyc sec filings - glycomimetics 10-k, 10-q, 8-k forms  Stock Titan Wed, 04 Mar 2026 11:02:32 GMT
 crescent biopharma - financial details  Crunchbase Mon, 02 Mar 2026 02:18:34 GMT
 glycomimetics revenue 2016-2023  Statista Tue, 10 Feb 2026 08:00:00 GMT
 can glycomimetics inc. stock beat market expectations this quarter  newser.com Fri, 21 Nov 2025 13:57:21 GMT
 crescent biopharma, inc. sec 10-q report  TradingView Thu, 06 Nov 2025 08:00:00 GMT
 published on: 2025-11-04 23:51:17  newser.com Wed, 05 Nov 2025 05:51:17 GMT

GlycoMimetics, Inc
(NASDAQ:GLYC) 

GLYC stock logo

GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. The company's drug candidate include rivipansel, a pan-selectin antagonist for the treatment ...

Founded: 2003
Full Time Employees: 57
Founder: Rachel K. King 
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends